相似文献
1
Anthracycline-induced phospholipase A2 inhibition.
Cardiovasc Toxicol. 2007;7(2):86-91. doi: 10.1007/s12012-007-0012-6.
2
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
Cancer Res. 2003 Sep 15;63(18):5992-8.
3
Changes in phospholipid content and myocardial calcium-independent phospholipase A2 activity during chronic anthracycline administration.
J Pharmacol Exp Ther. 2004 Nov;311(2):736-41. doi: 10.1124/jpet.104.069419. Epub 2004 Aug 4.
4
Effect of anthracyclines on phospholipase A2 activity and prostaglandin E2 production in rat gastric mucosa.
Biochem Pharmacol. 1993 Aug 3;46(3):349-55. doi: 10.1016/0006-2952(93)90509-u.
5
Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.
Pharmacol Rep. 2009 Jan-Feb;61(1):154-71. doi: 10.1016/s1734-1140(09)70018-0.
6
Phospholipase A2 inhibition at different substrate concentrations.
Anal Biochem. 2006 Dec 15;359(2):280-2. doi: 10.1016/j.ab.2006.08.031. Epub 2006 Sep 22.
7
Role of anthracyclines in the era of targeted therapy.
Cardiovasc Toxicol. 2007;7(2):56-60. doi: 10.1007/s12012-007-0015-3.
8
Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2.
Neuroscience. 2006 Jun 30;140(2):547-53. doi: 10.1016/j.neuroscience.2006.02.026. Epub 2006 Mar 23.
9
Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
J Biol Chem. 1987 Feb 5;262(4):1698-705.
10
Calmodulin-independent inhibition of platelet phospholipase A2 by calmodulin antagonists.
Arch Biochem Biophys. 1986 May 1;246(2):699-709. doi: 10.1016/0003-9861(86)90326-7.
引用本文的文献
1
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
Eur Heart J. 2022 Dec 21;43(48):4991-5002. doi: 10.1093/eurheartj/ehac495.
2
Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines.
Cardiooncology. 2018;4. doi: 10.1186/s40959-018-0030-5. Epub 2018 May 1.
3
Inhibition of iPLA2 β and of stretch-activated channels by doxorubicin alters dystrophic muscle function.
Br J Pharmacol. 2013 Aug;169(7):1537-50. doi: 10.1111/bph.12188.
4
Anthracycline cardiotoxicity: from bench to bedside.
J Clin Oncol. 2008 Aug 1;26(22):3777-84. doi: 10.1200/JCO.2007.14.9401.
5
The anthracyclines: when good things go bad.
Cardiovasc Toxicol. 2007;7(2):53-5. doi: 10.1007/s12012-007-0017-1.
本文引用的文献
1
Changes in phospholipid content and myocardial calcium-independent phospholipase A2 activity during chronic anthracycline administration.
J Pharmacol Exp Ther. 2004 Nov;311(2):736-41. doi: 10.1124/jpet.104.069419. Epub 2004 Aug 4.
2
Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
Cancer Res. 2003 Sep 15;63(18):5992-8.
3
Oxidant-induced inhibition of myocardial calcium-independent phospholipase A2.
Cardiovasc Toxicol. 2001;1(4):309-16. doi: 10.1385/ct:1:4:309.
4
Calcium and cardiac rhythms: physiological and pathophysiological.
Circ Res. 2002 Jan 11;90(1):14-7.
5
Clinical concentrations of doxorubicin inhibit activity of myocardial membrane-associated, calcium-independent phospholipase A(2).
Cancer Res. 2001 May 15;61(10):4024-9.
6
Redistribution and abnormal activity of phospholipase A(2) isoenzymes in postinfarct congestive heart failure.
Am J Physiol Cell Physiol. 2001 Mar;280(3):C573-80. doi: 10.1152/ajpcell.2001.280.3.C573.
7
Selective plasmalogen substrate utilization by thrombin-stimulated Ca(2+)-independent PLA(2) in cardiomyocytes.
Am J Physiol Heart Circ Physiol. 2000 Jun;278(6):H1933-40. doi: 10.1152/ajpheart.2000.278.6.H1933.
8
Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress.
Am J Physiol Heart Circ Physiol. 2000 Mar;278(3):H982-90. doi: 10.1152/ajpheart.2000.278.3.H982.
9
Persistent effects of doxorubicin on cardiac gene expression.
J Mol Cell Cardiol. 1999 Aug;31(8):1435-46. doi: 10.1006/jmcc.1999.0972.
10
Calcium-independent phospholipase A2 in isolated rabbit ventricular myocytes.
Lipids. 1998 Dec;33(12):1203-12. doi: 10.1007/s11745-998-0324-5.
Zotero 插件